KRAS and adenocarcinoma: The majority of mutant Kras-induced PanINs undergo senescence and require further mutations in tumour suppressors, such as Trp535,6, Cdkn2a7, Tgfbr28, Smad49 or Pten10,11, to progress into invasive adenocarcinomas.